Add Company
Join Now

Elixiron Immunotherapeutics Revenue and Competitors

License our Company Data API

Taipei,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Elixiron Immunotherapeutics's estimated annual revenue is currently $3.4M per year.(i)
  • Elixiron Immunotherapeutics's estimated revenue per employee is $155,000

Employee Data

  • Elixiron Immunotherapeutics has 22 Employees.(i)
  • Elixiron Immunotherapeutics grew their employee count by 5% last year.

Elixiron Immunotherapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Elixiron Immunotherapeutics?

Elixiron employs advances in translational medicine to identify targets from clinical observations, and various drug modalities including biologics derived from a proprietary single human B cell cloning platform to develop innovative therapies for malignant, immunological and degenerative diseases. Our lead pipeline candidates are EI-1071, a small molecule inhibitor of CSF1R kinase activity being explored as a potential therapy for Alzheimer's disease and to improve cancer immunotherapy by reducing immune suppression in tumors, and EI-001, a monoclonal antibody being investigated for treatment of chronic Hepatitis B and Vitiligo.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$3.4M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.4M2222%$20M
#2
$3.4M22-21%N/A
#3
$2.2M24-8%N/A
#4
$3.6M250%N/A
#5
$3.7M25-14%N/A